AGREEMENT AND PLAN OF MERGER BY AND AMONG CONTRAVIR PHARMACEUTICALS, INC., CICLOFILIN ACQUISITION CORP., CICLOFILIN PHARMACEUTICALS, INC. AND ROBERT FOSTER, PHARM.D., PH.D., AS STOCKHOLDER REPRESENTATIVE Dated as of May 26, 2016 AGREEMENT OF PLAN AND...Merger Agreement • October 29th, 2020 • Hepion Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This AGREEMENT AND PLAN OF MERGER, dated as of May 26, 2016 (this "Agreement"), is entered into by and among CONTRAVIR PHARMACEUTICALS, INC., a Delaware corporation ("Buyer"), CICLOFILIN ACQUISITION CORP., a Delaware corporation and a wholly-owned subsidiary of Buyer ("Merger Sub"), CICLOFILIN PHARMACEUTICALS, INC., a Delaware corporation ("Company"), and Robert Foster, Pharm.D., Ph.D., solely in his capacity as the representative of the Stockholders (the “Stockholder Representative”).
